These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. Matesic D, Valujskikh A, Pearlman E, Higgins AW, Gilliam AC, Heeger PS. J Immunol; 1998 Nov 15; 161(10):5236-44. PubMed ID: 9820495 [Abstract] [Full Text] [Related]
7. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K. Int Immunol; 2008 Oct 15; 20(10):1343-9. PubMed ID: 18697765 [Abstract] [Full Text] [Related]
9. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Youssef AR, Otley C, Mathieson PW, Smith RM. Transpl Immunol; 2004 Dec 15; 13(4):297-304. PubMed ID: 15589743 [Abstract] [Full Text] [Related]
10. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance. Jarvinen LZ, Blazar BR, Adeyi OA, Strom TB, Noelle RJ. Transplantation; 2003 Nov 15; 76(9):1375-9. PubMed ID: 14627918 [Abstract] [Full Text] [Related]
11. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS. Transpl Int; 2004 Aug 15; 17(7):351-61. PubMed ID: 15349720 [Abstract] [Full Text] [Related]
12. Critical role of OX40 in CD28 and CD154-independent rejection. Demirci G, Amanullah F, Kewalaramani R, Yagita H, Strom TB, Sayegh MH, Li XC. J Immunol; 2004 Feb 01; 172(3):1691-8. PubMed ID: 14734751 [Abstract] [Full Text] [Related]
13. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA. Blood; 2003 May 01; 101(9):3741-8. PubMed ID: 12521997 [Abstract] [Full Text] [Related]
14. Blockade of the OX40 ligand prolongs corneal allograft survival. Hattori T, Usui Y, Okunuki Y, Sonoda Y, Usui M, Takada E, Mizuguchi J, Yagita H, Okumura K, Akiba H, Takeuchi M. Eur J Immunol; 2007 Dec 01; 37(12):3597-604. PubMed ID: 18022861 [Abstract] [Full Text] [Related]